- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
(Neo)adjuvant approaches in lung cancer—paving the road to a cure ; volume:17 ; number:1 ; day:19 ; month:1 ; year:2024 ; pages:10-14 ; date:2.2024
Magazine of European Medical Oncology ; 17, Heft 1 (19.1.2024), 10-14, 2.2024
- Urheber
-
Wass, Romana
Hochmair, Maximilian
Lang, David
Horner, Andreas
Lamprecht, Bernd
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12254-023-00949-3
- URN
-
urn:nbn:de:101:1-2024041511145777806079
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wass, Romana
- Hochmair, Maximilian
- Lang, David
- Horner, Andreas
- Lamprecht, Bernd
- SpringerLink (Online service)
Ähnliche Objekte (12)
(Neo)adjuvant approaches: pavement on the road to cure—breast cancer
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy
Adjuvant breast cancer: (neo)adjuvant therapy for HER2-positive breast cancer : The best of ASCO 2019
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
Practical consensus recommendations for neo-adjuvant chemotherapy in triple negative breast cancer
Colorectal cancer in the elderly patient: the role of neo-adjuvant therapy
Neo-adjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Prospective, Randomized Study
The treatment of periarticular soft tissue sarcoma following neo-adjuvant radiotherapy: a cohort study
(Neo)adjuvant approaches: pavement on the road to cure—breast cancer
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy
Adjuvant breast cancer: (neo)adjuvant therapy for HER2-positive breast cancer : The best of ASCO 2019
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
Practical consensus recommendations for neo-adjuvant chemotherapy in triple negative breast cancer
Colorectal cancer in the elderly patient: the role of neo-adjuvant therapy
Neo-adjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Prospective, Randomized Study
The treatment of periarticular soft tissue sarcoma following neo-adjuvant radiotherapy: a cohort study
(Neo)adjuvant approaches: pavement on the road to cure—breast cancer
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
Proceedings of the 3rd International Congress on Neo-Adjuvant Chemotherapy
Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC
Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy
Adjuvant breast cancer: (neo)adjuvant therapy for HER2-positive breast cancer : The best of ASCO 2019
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
Practical consensus recommendations for neo-adjuvant chemotherapy in triple negative breast cancer
Colorectal cancer in the elderly patient: the role of neo-adjuvant therapy
Neo-adjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Prospective, Randomized Study